Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-06-10

Clinical Trial Update: Ramipril, Endothelial Function and Endothelial Progenitor Cells in Patients With Systemic Lupus Erythematosus [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial investigating ramipril's effects on endothelial function and endothelial progenitor cells in patients with systemic lupus erythematosus, comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramipril (ramipril)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Systemic Lupus Erythematosus | Phase 2, Phase 3 | Status: COMPLETED